Company BioNeutral Group, Inc.

Equities

BONU

US0906211034

Environmental Services & Equipment

Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for BioNeutral Group, Inc. -.--% -.--%

Business Summary

BioNeutral Group, Inc. is a life science specialty technology company. The Company has developed a novel combinational chemistry-based technology which can, in certain circumstances, neutralize harmful environmental contaminants, toxins and dangerous micro-organisms, including bacteria, viruses and spores. The Company is focused on developing and commercializing two classes of product formulations: antimicrobials, which are formulations designed to kill certain harmful microscopic living organisms, and bioneutralizers, which are formulations designed to destroy certain agents that are noxious and harmful to health and/or the environment. The Company refers to its anti­microbial formulations as its Ygiene products and its bioneutralizer formulations as its Ogiene products.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 59,484 0 0 90.01 %
Stock B 0 128,251 0 0
Stock C 0 56,081 0 0
Stock D 1 5,751,790,172 5,177,186,334 ( 90.01 %) 0
Stock E 0 53,491 0 0

Company contact information

BioNeutral Group, Inc.

211 Warren Street

07960, Newark

+

address BioNeutral Group, Inc.(BONU)
  1. Stock Market
  2. Equities
  3. BONU Stock
  4. Company BioNeutral Group, Inc.